Entheon Biomedical Corp has seen no insider trading activity within the last three months. The most recent transaction occurred on August 26, 2024, involving a sale of 150,000 shares by a significant security holder. Previous historical filings include a director purchase in April 2024 and an executive divestment during August 2022.